Book a demo

Chemical intelligence powered by cypris.ai

Glutathionylspermidine

(2S)-2-amino-5-[[(2R)-1-[[2-[3-(4-aminobutylamino)propylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid · also: N'-Glutathionylspermidine disulfide, N1-(gamma-L-glutamyl-L-cysteinyl-glycyl)-spermidine, L-gamma-Glutamyl-L-cysteinyl-N-(3-((4-aminobutyl)amino)propyl)glycinamide, (2S)-2-amino-5-(((2R)-1-((2-(3-(4-aminobutylamino)propylamino)-2-oxoethyl)amino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoic acid, (2S)-2-amino-4-(((1R)-1-((((3-((4-aminobutyl)amino)propyl)-C-hydroxycarbonimidoyl)methyl)-C-hydroxycarbonimidoyl)-2-sulfanylethyl)-C-hydroxycarbonimidoyl)butanoic acid

FormulaC17H34N6O5S
Mol. weight434.556
PubChem CID440772
InChIKeyNEDQLXHBVHSKNV-STQMWFEESA-N
SMILESC(CCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)O)N)CN
41Patents
35Research papers
1Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Nuevolution AS10
2Xrpro Sciences Inc5
3Defined Diagnostics LLC2
4The University of Texas System2
5University of California2
6University of California, San Diego2
7Icagen Inc1
8Icagen LLC1
9University of California Berkeley1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C12NMicroorganisms, enzymes26
2G01NInvestigating / analysing materials15
3A61KMedicinal preparations11
4A61PTherapeutic activity (drug indications)11
5C40B9
6G21K8
7C12QMeasuring/testing involving enzymes7
8Y10SCross-reference (legacy)7
9C12PFermentation, enzyme processes4
10A01NPreservation of bodies; biocides; pest repellents2

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
Glutathionylspermidine synthetase2001LEOPOLD FLOHE0
GLUTATHIONYLSPERMIDINE SYNTHETASE2000FLOHE LEOPOLD0
Glutathionylspermidine synthetase2000LEOPOLD FLOHE0
GLUTATHIONYLSPERMIDINE SYNTHETASE1999FLOHE, LEOPOLD, PROF. DR.0
Glutathionylspermidine synthetase1998FLOHE, LEOPOLD0

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Exercise and Physiological Responses1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Alan H. FairlambWellcome Trust7
2R. Luise Krauth‐SiegelHeidelberg University6
3Chun‐Hung LinNational Taiwan University5
4Leopold FlohéUniversity of Padua5
5Christopher T. WalshHarvard University4
6Marcelo A. CominiInstitut Pasteur de Montevideo4
7Bing‐Yu ChiangInstitute of Biological Chemistry, Academia Sinica3
8David S. KwonHarvard University3
9James K. CowardUniversity of Michigan3
10Mark R. AriyanayagamUniversity of London3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of glutathionylspermidine?

Glutathionylspermidine has the molecular formula C17H34N6O5S and a molecular weight of 434.556 daltons.

Which organizations hold the most patents related to glutathionylspermidine?

Nuevolution AS holds the most patents with 10, followed by Xrpro Sciences Inc with 5 patents. Defined Diagnostics LLC, The University of Texas System, University of California, and University of California, San Diego each hold 2 patents.

Who are the most prolific authors publishing on glutathionylspermidine research?

Alan H. Fairlamb from the Wellcome Trust has published 7 papers on this compound, followed by R. Luise Krauth‐Siegel from Heidelberg University with 6 papers. Chun‐Hung Lin from National Taiwan University and Leopold Flohé from University of Padua each have 5 papers.

What patent classifications are most commonly associated with glutathionylspermidine patents?

The most frequent CPC subclass is C12N with 26 patents, followed by G01N with 15 patents and A61K with 11 patents. A61P also appears in 11 patents, while C40B appears in 9 patents.

What were the key historical patents on glutathionylspermidine synthetase?

Early patents on glutathionylspermidine synthetase were filed between 1998 and 2001, including Australian patent AU-5662798-A (1998), European patent EP-0948627-A2 (1999), Brazilian patent BR-9714025-A (2000), and Korean patent KR-20000057483-A (2000), with New Zealand patent NZ-335967-A following in 2001.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial